ANCR vs. AGY, BXP, CEL, EAH, APH, VLG, BMK, 4BB, FARN, and EKF
Should you be buying Animalcare Group stock or one of its competitors? The main competitors of Animalcare Group include Allergy Therapeutics (AGY), Beximco Pharmaceuticals (BXP), Celadon Pharmaceuticals (CEL), ECO Animal Health Group (EAH), Alliance Pharma (APH), Venture Life Group (VLG), Benchmark (BMK), 4basebio (4BB), Faron Pharmaceuticals Oy (FARN), and EKF Diagnostics (EKF). These companies are all part of the "medical" sector.
Allergy Therapeutics (LON:AGY) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, community ranking, risk, profitability, valuation and earnings.
Animalcare Group has higher revenue and earnings than Allergy Therapeutics. Allergy Therapeutics is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Allergy Therapeutics had 2 more articles in the media than Animalcare Group. MarketBeat recorded 2 mentions for Allergy Therapeutics and 0 mentions for Animalcare Group. Allergy Therapeutics' average media sentiment score of 0.00 beat Animalcare Group's score of -0.09 indicating that Animalcare Group is being referred to more favorably in the news media.
Allergy Therapeutics has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, Animalcare Group has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500.
Animalcare Group has a net margin of 1.66% compared to Animalcare Group's net margin of -72.28%. Allergy Therapeutics' return on equity of 1.45% beat Animalcare Group's return on equity.
Allergy Therapeutics received 207 more outperform votes than Animalcare Group when rated by MarketBeat users. Likewise, 77.97% of users gave Allergy Therapeutics an outperform vote while only 69.37% of users gave Animalcare Group an outperform vote.
0.1% of Allergy Therapeutics shares are held by institutional investors. Comparatively, 44.7% of Animalcare Group shares are held by institutional investors. 93.2% of Allergy Therapeutics shares are held by insiders. Comparatively, 29.7% of Animalcare Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Animalcare Group beats Allergy Therapeutics on 9 of the 15 factors compared between the two stocks.
Get Animalcare Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for ANCR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ANCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Animalcare Group Competitors List
Related Companies and Tools